N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

McCallum, Matthew, De Marco, Anna, Lempp, Florian A., Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex +26 more·2021·Cell

Cited by (909)

Items 601–700 of 909

  1. Design and Immunoinformatic Assessment of Candidate Multivariant mRNA Vaccine Construct against Immune Escape Variants of SARS-CoV-2
    Mushtaq Hussain, Anusha Amanullah, Ayesha Aslam, Fozia Raza, Shabana Arzoo, Iffat Waqar Qureshi, Humera Waheed, Nusrat Jabeen, Sanya Shabbir, Muneeba Ahsan Sayeed et al. · 2022 · Polymers
  2. Involvement of sialoglycans in SARS‐COV ‐2 infection: Opportunities and challenges for glyco‐based inhibitors
    Sakonwan Kuhaudomlarp, Anne Imberty · 2022 · IUBMB Life
  3. Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in Children
    Pasquale Castaldo, Gabriele d’Alanno, Giovanni Battista Biserni, Mattia Moratti, Francesca Conti, Marianna Fabi, Marcello Lanari · 2023 · Pathogens
  4. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2
    Paula Ruiz-Rodríguez, Clara Francés-Gómez, Álvaro Chiner‐Oms, Mariana G. López, Santiago Jiménez-Serrano, Irving Cancino‐Muñoz, Paula Ruiz-Hueso, Manuela Torres‐Puente, Maria Alma Bracho, Giuseppe D’Auria et al. · 2021 · mBio
  5. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
    Prerna Arora, Amy Madeleine Kempf, Inga Nehlmeier, Luise Graichen, Martin Sebastian Winkler, Martin Lier, Sebastian R. Schulz, Hans‐Martin Jäck, Anne Cossmann, Metodi V. Stankov et al. · 2022 · Cell Reports
  6. The Emergence of SARS-CoV-2 Variants With a Lower Antibody Response: A Genomic and Clinical Perspective
    Suvro Biswas, Shafi Mahmud, Mohasana Akter Mita, Shamima Afrose, Md. Robiul Hasan, Gobindo Kumar Paul, Mst. Sharmin Sultana Shimu, Md. Salah Uddin, Shahriar Zaman, Moon Nyeo Park et al. · 2022 · Frontiers in Medicine
  7. Immune-based therapeutic approaches in COVID-19
    Aysan Moeinafshar, Niloufar Yazdanpanah, Nima Rezaei · 2022 · Biomedicine & Pharmacotherapy
  8. SARS-CoV-2 Delta variant isolates from vaccinated individuals
    Lauren M. Brinkac, Sheila Diepold, Shane Mitchell, Stephanie Sarnese, Lee F. Kolakowski, William M. Nelson, Katharine Jennings · 2022 · BMC Genomics
  9. Analysis of SARS-CoV-2 Mutations Over Time Reveals Increasing Prevalence of Variants in the Spike Protein and RNA-Dependent RNA Polymerase
    William M. Showers, Sonia M. Leach, K. Kechris, M. Strong · 2021 · bioRxiv
  10. A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaques
    Jiaping Yu, Wenrong Yao, Yingsong Hu, Shuang Wu, Jiao Li, Hongjun Zhou, Kunxue Hong, Jianping Chen, Longding Liu, Ke Lan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
    Alexandra C. Walls, Kaitlin R. Sprouse, Anshu Joshi, John E. Bowen, Nicholas Franko, Mary Jane Navarro, Cameron Stewart, Matthew McCallum, Erin A. Goecker, Emily Degli-Angeli et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Reverse mutational scanning of spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal sera
    Najat Bdeir, Tatjana Lüddecke, Henrike Maaß, Stefan Schmelz, Ulfert Rand, Henning Jacobsen, Kristin Metzdorf, Upasana Kulkarni, Anne Cossmann, Metodi V. Stankov et al. · 2024 · medRxiv
  13. Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies
    Wenling Jiang, Yanan Jiang, Hui Sun, Tingting Deng, Kunyu Yu, Qianjiao Fang, Huimin Ge, Miaoling Lan, Yanling Lin, Zhongyue Fang et al. · 2024 · Emerging Microbes & Infections
  14. RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques
    Hélène Letscher, Delphine Guilligay, Grégory Effantin, Axelle Amen, Guidenn Sulbarán, Judith A. Burger, Laëtitia Bossevot, Laura Junges, Marco Léonec, Julie Morin et al. · 2025 · npj Vaccines
  15. A rare B cell clonotype imprinted by ancestral SARS-CoV-2 develops cross-sarbecovirus neutralization in immune recalls
    Xixian Chen, Ling Li, Ruiping Du, Zuowei Wang, Yunjian Li, Yi Sun, Rongrong Qin, Hualong Feng, Lin Hu, Xuanyi Chen et al. · 2025 · Cell Reports
  16. Functional and structural basis of Omicron BA.3.2.1 spike
    Yan Wang, Yanping Hu, Zhenhang Chen, Jing Zou, Ke Zhang, Ping Ren, Pei‐Yong Shi, Bo Liang, Xuping Xie · 2026 · Cell Reports
  17. Mutational escape prevention by combination of four neutralizing antibodies that target RBD conserved regions and stem helix
    Haoneng Tang, Yong Ke, Yunji Liao, Yanlin Bian, Yunsheng Yuan, Ziqi Wang, Yang Li, Hang Ma, Tao Sun, Baohong Zhang et al. · 2022 · Virologica Sinica
  18. Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants
    Wenjuan Du, Rick Janssens, Anna Z. Mykytyn, Wentao Li, Dubravka Drabek, Rien van Haperen, Marianthi Chatziandreou, Melanie Rissmann, Joline van der Lee, Melissa van Dortmondt et al. · 2023 · Frontiers in Immunology
  19. Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals
    Eugenia Galeota, Valeria Bevilacqua, Andrea Gobbini, Paola Gruarin, Mauro Bombaci, Elisa Pesce, Andrea Favalli, Andrea Lombardi, Francesca Vincenti, Jessica Ongaro et al. · 2024 · Clinical Immunology
  20. Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected Chlorocebus aethiops (African Green Monkeys)
    Lori A. Rowe, Brandon J. Beddingfield, Kelly A. Goff, Stephanie Z. Killeen, Nicole R. Chirichella, Alexandra Melton, Chad J. Roy, Nicholas J. Maness · 2022 · Viruses
  21. Phylogenetic analysis and comparative genomics of SARS-CoV-2 from survivor and non-survivor COVID-19 patients in Cordoba, Argentina
    Nadia B. Olivero, Ana Silvia Gonzalez-Reiche, Viviana Elizabeth Re, Gonzalo Castro, María Belén Pisano, Paola E. Sicilia, María Gabriela Barbás, Zenab Khan, Adriana van de Guchte, Jayeeta Dutta et al. · 2022 · BMC Genomics
  22. Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview
    Nastaran Hadizadeh, Mousa Naderi, Jafar Khezri, Meysam Yazdani, Mehdi Shamsara, Ehsan Hashemi · 2022 · Journal of Diabetes & Metabolic Disorders
  23. Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey
    Barun Mathema, Liang Chen, Pengfei Wang, Marcus H. Cunningham, José R. Mediavilla, Kar Fai Chow, Yang Luo, Yanan Zhao, Kaelea Composto, Jerry M. Zuckerman et al. · 2022 · mBio
  24. Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learner
    Xin Wang, Mingda Hu, Bo Liu, Huifang Xu, Yuan Jin, Boqian Wang, Yunxiang Zhao, Jun Wu, Junjie Yue, Hongguang Ren · 2023 · Frontiers in Cellular and Infection Microbiology
  25. Highly sensitive wastewater surveillance of SARS-CoV-2 variants by targeted next-generation amplicon sequencing provides early warning of incursion in Victoria, Australia
    James E. Merrett, Monica Nolan, Leon M. Hartman, Nijoy John, Brianna Flynn, Louise Baker, Christelle Schang, David McCarthy, David Lister, Ngai Ning Cheng et al. · 2024 · Applied and Environmental Microbiology
  26. Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS‐CoV ‐2
    Bharat Madan, Eswar R. Reddem, Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Yaoxing Huang, Ahmed S. Fahad, Matheus Oliveira de Souza, Bailey B. Banach, Sheila N. López Acevedo et al. · 2021 · AIChE Journal
  27. Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner Sardinia
    Paolo Malune, Giovanna Piras, Maria Itria Monne, Maura Fiamma, Rosanna Asproni, Tatiana Fancello, Antonio Luigi Manai, Franco Carta, Giovanna Pira, Patrizia Fancello et al. · 2022 · Frontiers in Microbiology
  28. Whole-Genome Sequencing of SARS-CoV-2 Infection in a Cluster of Immunocompromised Children in Indonesia
    Nina Dwi Putri, Edison Johar, Yora Permata Dewi, Nuri Dyah Indrasari, Dewi Wulandari, Merci Monica Pasaribu, Teny Tjitra Sari, Fitri Prima Cakti, Madeline Ramdhani Jasin, Tartila Tartila et al. · 2022 · Frontiers in Medicine
  29. A Short Series of Case Reports of COVID-19 in Immunocompromised Patients
    Mitali Mishra, Aleena Zahra, Lokendra V. Chauhan, Riddhi Thakkar, James Ng, Shreyas Joshi, Eric D. Spitzer, Luis A. Marcos, Walter Ian Lipkin, Nischay Mishra · 2022 · Viruses
  30. Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2
    Ruba Al Khalaf, Anna Bernasconi, Pietro Pinoli, Stefano Ceri · 2022 · Computational and Structural Biotechnology Journal
  31. Evolution of the SARS-CoV-2 pandemic in India
    Varsha Atul Potdar, Sarah Cherian · 2022 · Medical Journal Armed Forces India
  32. High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
    Timothy J.C. Tan, Zongjun Mou, Ruipeng Lei, Wenhao O. Ouyang, Meng Yuan, Ge Song, Raiees Andrabi, Ian A. Wilson, Collin Kieffer, Xinghong Dai et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Spike Protein–Fibrinogen Interaction: A Novel Immune Evasion Strategy of SARS-CoV-2?
    Saroj Kumar Panda, Shashi Bala Singh, Parth Sarthi Sen Gupta · 2025 · ACS Pharmacology & Translational Science
  34. Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines
    Sandhya Bangaru, Abigail M. Jackson, Jeffrey Copps, Monica L. Fernández‐Quintero, Jonathan L. Torres, Sara T. Richey, Bartek Nogal, Leigh M. Sewall, Alba Torrents de la Peña, Asma Rehman et al. · 2025 · Cell Reports
  35. Heterogeneous Evolution Among SARS‐CoV‐2 Genes and Variants of Concern
    Luis Daniel González-Vázquez, Paula Iglesias-Rivas, David Ferreiro, Miguel Arenas · 2025 · Journal of Medical Virology
  36. Repeated COVID-19 vaccine boosters elicit variant-specific memory B cells in humans
    M. Alejandra Tortorici, Kaitlin R. Sprouse, Amin Addetia, Jack T Brown, Jimin Lee, Cameron Stewart, Benjamin Merz, Alex Harteloo, Anna Elias-Warren, Helen Y. Chu et al. · 2026 · Cell Reports
  37. Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
    Shuchen Feng, Gail Reid, Nina M. Clark, Amanda Harrington, Susan L. Uprichard, Susan C. Baker · 2024 · Virology Journal
  38. Advancements in the Development of Anti-SARS-CoV-2 Therapeutics
    Junjie Huang, Qianqian Ma, Zhengding Su, Xiyao Cheng · 2024 · International Journal of Molecular Sciences
  39. Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV
    Naveenchandra Suryadevara, Nurgun Kose, Sandhya Bangaru, Elad Binshtein, Jennifer E. Munt, David R. Martinez, Alexandra Schäfer, Luke Myers, Trevor Scobey, Robert H. Carnahan et al. · 2024 · Journal of Clinical Investigation
  40. Gene expression analysis of MCF7 cell lines of breast cancer treated with herbal extract of Cissampelos pareira revealed association with viral diseases
    Emine Güven · 2021 · Gene Reports
  41. Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells
    Gladys J. Keitany, Benjamin E. Rubin, Meghan E. Garrett, Andrea Musa, Jeff Tracy, Yu Liang, Peter Ebert, Amanda J. Moore, Jonathan Guan, Erica L. Eggers et al. · 2023 · Cell chemical biology
  42. Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects
    Richard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn, Tobias Max Nowacki, Jörn Arne Meier, Jonel Trebicka, Phil‐Robin Tepasse · 2023 · Vaccines
  43. Neutralization of Different Variants of SARS-CoV-2 by a F(ab′)2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding Domain
    Mariajosé Rodríguez, Mariana del Valle Cepeda, Carlos Bello, Miguel Angel Lopez, Yoneira Fabiola Sulbarán, Carmen Luisa Loureiro, Ferdinando Liprandi, Rossana Celeste Jaspe, Hector Rafael Rangel, Flor Helene Pujol · 2023 · Antibodies
  44. Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort
    Michael Schöfbänker, Rieke Neddermeyer, Theresa Günther, MM Mueller, Marie-Luise Romberg, Nica Classen, Marc Tim Hennies, Eike Roman Hrincius, Stephan Ludwig, Joachim Kühn et al. · 2023 · Vaccines
  45. Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
    Ketaren, Natalia E, Mast, Fred D, Fridy, Peter C, Olivier, Jean Paul, Sanyal, Tanmoy, Sali, Andrej, Chait, Brian T, Rout, Michael P, Aitchison, John D · 2024 · eLife
  46. Enhanced antibody response to the conformational non-RBD region via DNA prime-protein boost elicits broad cross-neutralization against SARS-CoV-2 variants
    Yun-Fei Ma, Kun Chen, Bowen Xie, Jiayi Zhu, Xuan He, Chunying Chen, Yuhe Renee Yang, Ye Liu · 2024 · Emerging Microbes & Infections
  47. Persistence of SARS-CoV-2 Alpha Variant in White-Tailed Deer, Ohio, USA
    Natalie N. Tarbuck, Sofya K. Garushyants, Dillon S. McBride, Patricia M. Dennis, John Franks, Karlie Woodard, Austin Shamblin, Michael G. Sovic, Derek T. Collins, Kyle Van Why et al. · 2025 · Emerging infectious diseases
  48. Mutational profile confers increased stability of SARS-CoV-2 spike protein in Brazilian isolates
    Felipe Rocha da Silva Santos, Marcela Santiago Pacheco de Azevedo, Mônica Bielavsky, Hernan Hermes Monteiro da Costa, Daniela Gomes Ribeiro, Gleidson Guedes do Nascimento, Gabrielle Menezes Paz Marcondes, Beatriz Portugal de Castro, Daniel Ferreira de Lima Neto, Carlos Roberto Prudêncio · 2021 · Journal of Biomolecular Structure and Dynamics
  49. Predicting spike protein NTD mutations of SARS-CoV-2 causing immune evasion by molecular dynamics simulations
    Liping Zhou, Leyun Wu, Cheng Peng, Yanqing Yang, Yulong Shi, Likun Gong, Zhijian Xu, Weiliang Zhu · 2022 · Physical Chemistry Chemical Physics
  50. Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
    Yinon Levy, Ron Alcalay, Anat Zvi, Efi Makdasi, Eldar Peretz, Tal Noy-Porat, Theodor Chitlaru, Michal Mandelboim, Ohad Mazor, Ronit Rosenfeld · 2022 · Vaccines
  51. Host–pathogen dynamics in longitudinal clinical specimens from patients with COVID-19
    Michelle J. Lin, Victoria M. Rachleff, Hong Jian Xie, Lasata Shrestha, Nicole A. P. Lieberman, Vikas Peddu, Amin Addetia, Amanda M. Casto, Nathan Breit, Patrick C. Mathias et al. · 2022 · Scientific Reports
  52. Detecting Potentially Adaptive Mutations from the Parallel and Fixed Patterns in SARS-CoV-2 Evolution
    Chengyang Ji, Na Han, Ye‐Xiao Cheng, Jingzhe Shang, Shenghui Weng, Rong Yang, Hangyu Zhou, Aiping Wu · 2022 · Viruses
  53. Mutational induction in SARS-CoV-2 major lineages by experimental exposure to neutralising sera
    Martina Brandolini, Giorgio Dirani, Francesca Taddei, Silvia Zannoli, Agnese Denicolò, Valentina Arfilli, Arianna Battisti, Martina Manera, Andrea Mancini, Laura Grumiro et al. · 2022 · Scientific Reports
  54. Tracking mutational semantics of SARS-CoV-2 genomes
    Rohan P. Singh, Sunil Nagpal, Nishal Kumar Pinna, Sharmila S. Mande · 2022 · Scientific Reports
  55. Coronavirus Entry Inhibitors
    Qiaoshuai Lan, Shuai Xia, Lu Lu · 2022 · Advances in experimental medicine and biology
  56. Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals
    Aurélien Sokal, Giovanna Barba Spaeth, Ignacio Fernández, Matteo Broketa, Imane Azzaoui, Andrea de La Selle, Alexis Vandenberghe, Slim Fourati, Anaïs Roeser, Annalisa Meola et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  57. B.1.617.3 SARS CoV-2 spike E156G/Δ157-158 mutations contribute to reduced neutralization sensitivity and increased infectivity
    Tarun Kumar Mishra, Garima Joshi, Atul Kumar, Rishikesh Dalavi, Pankaj Pandey, Sanjeev Shukla, Ram Kumar Mishra, Ajit G. Chande · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Structural basis for antibody resistance to SARS-CoV-2 omicron variant
    Gabriele Cerutti, Yicheng Guo, Lihong Liu, Zhening Zhang, Liyuan Liu, Yang Luo, Yiming Huang, Harris H. Wang, David D. Ho, Zizhang Sheng et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Identification and genomic characterisation of BA.3.2: a highly divergent BA.3-related SARS-CoV-2 lineage from southern Africa
    Graeme Dor, Dikeledi Kekana, Ryan Hisner, Darren Patrick Martin, Bette Korber, Timo Ernst, Avram Levy, David John Speers, Stuart Grant Turville, Vitali Sintchenko et al. · 2025 · medRxiv
  60. Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses
    Rafael Bayarri‐Olmos, Adrian Sutta, Anne Rosbjerg, Mie Mandal Mortensen, Charlotte Helgstrand, Per Franklin Nielsen, Laura Pérez‐Alós, Beatriz González‐García, Laust Bruun Johnsen, Finn Matthiesen et al. · 2024 · Frontiers in Immunology
  61. Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections
    Grace Quirk, Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Branden Lau, Chieh-Yu Liang, Jefferey L. Burgess, Katherine Ellingson, Shawn C. Beitel, James K. Romine et al. · 2025 · Nature Immunology
  62. Discovery of Synergistic Broadly Neutralizing Antibodies Targeting Non-Dominant Epitopes on SARS-CoV-2 RBD and NTD
    Hualong Feng, Zuowei Wang, Ling Li, Yunjian Li, Maosheng Lu, Xixian Chen, Lin Hu, Yi Sun, Ruiping Du, Rongrong Qin et al. · 2025 · Vaccines
  63. Structural Analysis of the SARS ‐ CoV ‐2 Spike N‐Terminal Domain Across Wild‐Type and Recent Variants: A Comparative Study
    Miriana Quaranta, Allegra Via, Stefano Pascarella · 2025 · Proteins Structure Function and Bioinformatics
  64. An Electrostatically-steered Conformational Selection Mechanism Promotes SARS-CoV-2 Spike Protein Variation
    Marija Sorokina, Jaydeep Belapure, Christian Tüting, Reinhard Paschke, Ioannis Papasotiriou, João Rodrigues, Panagiotis L. Kastritis · 2022 · Journal of Molecular Biology
  65. Multiplex RT Real-Time PCR Based on Target Failure to Detect and Identify Different Variants of SARS-CoV-2: A Feasible Method That Can Be Applied in Clinical Laboratories
    Van Hung Pham, Huong Thien Pham, Mario Giosuè Balzanelli, Pietro Distratis, Rita Lazzaro, Quốc Việt Nguyễn, Viet Quoc Tran, Duy Khanh Tran, Luan Duy Phan, Sang Minh Pham et al. · 2023 · Diagnostics
  66. The Lambda Variant in Argentina: Analyzing the Evolution and Spread of SARS-CoV-2 Lineage C.37
    Mercedes Soledad Nabaes Jodar, Carolina Torres, Laura Noelia Mojsiejczuk, Dolores Acuña, Laura Elena Valinotto, Stephanie Goya, Mónica Inés Natale, Silvina Beatriz Lusso, Sofía Alexay, Ariel Amadío et al. · 2023 · Viruses
  67. Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review)
    Tong Zhang, Di Yang, Liang Tang, Yu Hu · 2024 · Molecular Medicine Reports
  68. Unraveling the structural and functional dimensions of SARS-CoV2 proteins in the context of COVID-19 pathogenesis and therapeutics
    Aniruddh Jhanwar, Dipika Sharma, Uddipan Das · 2024 · International Journal of Biological Macromolecules
  69. Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients
    Luca Ruotolo, Silvia Silenzi, Beatrice Mola, Margherita Ortalli, Tiziana Lazzarotto, Giada Rossini · 2024 · Virology Journal
  70. Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics
    Madeeha Afzal, Diana Melnyk, Thomas Courty, Lisa M. Schimanski, Michelle L. Hill, Stuart J. D. Neil, Tiong Kit Tan, William James · 2025 · iScience
  71. Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
    AJ Venkatakrishnan, Praveen Anand, Patrick J. Lenehan, Pritha Ghosh, Rohit Suratekar, Eli Silvert, Colin Pawlowski, Abhishek Siroha, Dibyendu Roy Chowdhury, John Charles O’Horo et al. · 2023 · Scientific Reports
  72. SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain
    Jianhua Li, Xiaoyan Li, Haiyan Mao, Chen Huang, Yi Sun, Liangbin Miao, Jiaxuan Li, Wanchen Song, Yanjun Zhang, Jinsong Huang et al. · 2023 · Virus Research
  73. Subunit vaccine raised against the SARS‐CoV‐2 spike of Delta and Omicron variants
    Feng Sheng, Zechang Fan, Keyue Zhou, Shanshan Ma, Mingzheng Liang, He Zhang, Yubiao Xie, Zhuo Ha, Ningyi Jin, Huijun Lu · 2023 · Journal of Medical Virology
  74. Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants
    Kan Li, Richard H. C. Huntwork, G. Horn, Milite Abraha, K. Hastie, Hao-Yang Li, Vamseedhar Rayaprolu, Eduardo Olmedillas, E. Feeney, Ken Cronin et al. · 2023 · Journal of Virology
  75. Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigen
    Linwood Johnson, Maggie L. Bartlett, Francisco Ramirez, Christopher D. Heger, Darci R. Smith · 2023 · Journal of Immunological Methods
  76. Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves
    Han Di, Elizabeth A. Pusch, Joyce E. Jones, Nicholas A. Kovacs, Norman Hassell, Mili Sheth, Kelly Sabrina Lynn, Matthew W. Keller, Malania M. Wilson, Lisa Mari Keong et al. · 2024 · Vaccines
  77. Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
    Rong Xiang, Yang Wang, Lili Wang, Xiaoqian Deng, Shanshan Huo, Shibo Jiang, Fei Yu · 2021 · Current Opinion in Virology
  78. Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
    Katharina Müller, Philipp Girl, Andreas Giebl, Stefanie Grützner, Markus H. Antwerpen, Elham Khatamzas, Roman Wölfel, Heiner von Buttlar · 2021 · Virus Genes
  79. Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2
    Su Jin Lee, Yujin Kim, Dae‐Gyun Ahn · 2022 · Journal of Microbiology and Biotechnology
  80. SARS-CoV-2 variants of concern, variants of interest and lineage A.27 are on the rise in Côte d’Ivoire
    Etilé A. Anoh, Grit Schubert, Oby Wayoro, Pacôme Monemo, Essia Belarbi, Andreas Sachse, Sébastien Calvignac‐Spencer, Fabian Hubertus Leendertz, Bamourou Diané, Chantal G. Akoua-Koffi · 2021 · medRxiv
  81. SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodies
    Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Monika Patel, Robin Gopal, Luke Muir, Felicity Aiano, Katie J. Doores, J. Yimmy Chow et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  82. A novel B.1.1.523 SARS-CoV-2 variant that combines many spike mutations linked to immune evasion with current variants of concern
    Brian M. J. W. van der Veer, Jozef Dingemans, Lieke B. van Alphen, Christian J. P. A. Hoebe, Paul H. M. Savelkoul · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike
    Marco Aurelio Díaz-Salinas, Qi Li, Monir Ejemel, Leonid Yurkovetskiy, Jeremy Luban, Kuang Shen, Yang Wang, James B. Munro · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  84. Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
    Valeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, Dietmar Hammerschmid, Katie J. Doores, Richard T. Bradshaw, Ricardo B. Parsons, Donald J. Benton, Chloë Roustan, Eamonn Reading et al. · 2022 · Research Square
  85. Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
    Filippo Bianchini, Virginia Crivelli, Morgan E. Abernathy, Concetta Guerra, Martin Palus, Jonathan Muri, Harold Marcotte, Antonio Piralla, Mattia Pedotti, Raoul De Gasparo et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment
    Caterina Elisa Faliti, Fabliha A. Anam, Narayanaiah Cheedarla, Matthew Charles Woodruff, Sabeena Y. Usman, Martin C. Runnstrom, Trinh T. P. Van, Shuya Y. Kyu, Hasan Ahmed, Andrea Morrison-Porter et al. · 2023 · medRxiv
  87. Recombination Events Among SARS-CoV-2 Omicron Subvariants: Impact on Spike Interaction With ACE2 Receptor and Neutralizing Antibodies
    Marwa Arbi, Marwa Khedhiri, Kaouther Ayouni, Oussema Souiai, Samar Dhouib, Nidhal Ghanmi, Alia Benkahla, Henda Triki, S Boubaker · 2024 · Evolutionary Bioinformatics
  88. Decoding omicron: Genetic insight into its transmission dynamics, severity spectrum and ever-evolving strategies of immune escape in comparison with other SARS-CoV-2 variants
    Kundan Tandel, Divya Niveditha, Sanjay Pratap Singh, Kavita Bala Anand, Vaishnavi Shinde, Mayank Ghedia, Ashwini Sondakar, Mahesh Reddy · 2025 · Diagnostic Microbiology and Infectious Disease
  89. Differential severity of SARS-CoV-2 variant infections in children and adults with COVID-19
    Noah Brazer, Venice Servellita, Chengshi Jin, Abiodun Foresythe, Miriam Oseguera, Jenny Nguyen, Nanami Sumimoto, Hee Jae Huh, Andries Feder, Sanchita Bhattacharya et al. · 2025 · Journal of Clinical Virology
  90. Investigating the evolutionary dynamics and mutational pattern of SARS-CoV-2 spike gene on selected SARS-CoV-2 variants
    Bachir Balech, Alessandra Lo Presti, Claudia Telegrafo, Lucia Maisto, Emanuela Giombini, Angela Di Martino, Luigina Ambrosio, Apollonia Tullo, Paola Stefanelli · 2025 · PLoS ONE
  91. Detection and differentiation of murine leukemia virus (MLV) and murine stem cell virus (MSCV) and therefrom derived nucleic acids
    Wolfram Volkwein, Melanie Pavlovic, Martina Anton, Maren Haase, Thorsten Stellberger, Amin Jarrar, Ulrich Busch, Armin E. Baiker · 2021 · Journal of Virological Methods
  92. Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity
    Rebecca Jonczyk, Nils Stanislawski, Lisa K. Seiler, Somayeh Ahani, Arne Bueltemeier, Frank Stahl, Sascha Beutel, Holger Blume, Corinna Hauß, Anette Melk et al. · 2022 · Journal of Clinical Virology
  93. Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein
    Xiaofeng Li, Liudmila Kulakova, Kezzia S. Jones, E. Toth, M. Mitchell, Qiana Mendez, Michael P. Weiner, T. Fuerst · 2023 · New Biotechnology
  94. Identification of an IGHV3-53-Encoded RBD-Targeting Cross-Neutralizing Antibody from an Early COVID-19 Convalescent
    Yuanyuan Hu, Caiqin Hu, Shuo Wang, Li Ren, Yanling Hao, Zheng Wang, Ying Liu, Junwei Su, Biao Zhu, Dan Li et al. · 2024 · Pathogens
  95. Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins
    Hasan, Muhammad, He, Zhouyi, Jia, Mengqi, Leung, Alvin C.F., Natarajan, Kathiresan, Xu, Wentao, Yap, Shanqi, Zhou, Feng, Chen, Shihong, Su, Hailei et al. · 2024 · Computational and Structural Biotechnology Journal
  96. Progressive Evolutionary Dynamics of Gene-Specific ω Led to the Emergence of Novel SARS-CoV-2 Strains Having Super-Infectivity and Virulence with Vaccine Neutralization
    Amit K. Maiti · 2024 · International Journal of Molecular Sciences
  97. Enhanced detection and molecular modeling of adaptive mutations in SARS-CoV-2 coding and non-coding regions using the c/µ test
    Nicholas Joseph Paradis, Chun Fu Wu · 2024 · Virus Evolution
  98. Proteomic Approach for Comparative Analysis of the Spike Protein of SARS-CoV-2 Omicron (B.1.1.529) Variant and Other Pango Lineages
    Mukul Jain, Nil Patil, Darshil Gor, Mohit Kumar Sharma, Neha Goel, Prashant Kaushik · 2022 · Proteomes
  99. Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
    Yuqi Zhu, Xinyi Yang, Jingna Xun, Jun Liu, Qing Wen, Yixiao Lin, Xiaoting Shen, Jun Chen, Songhua Yuan, Xiaying Zhao et al. · 2022 · Virologica Sinica
  100. SARS-CoV-2 Omicron Variant Genomic and Phylogenetic Analysis in Iraqi Kurdistan Region
    Sevan Omer Majed, Suhad Asad Mustafa, Paywast Jamal Jalal, Mohammed Hassan Fatah, Monika Henryka Miasko, Zanko Hassan Jawhar, A. Karim · 2023 · Genes